Market Research Logo

Ophthalmology Drugs Global Market Report 2018 Including: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological DrugsCovering: Novartis AG,F. Hoffmann-La Roche Ltd,Allergan Plc,Valeant Pharmaceuticals Intl Inc,Bayer AG

Ophthalmology Drugs Global Market Report 2018 Including: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological DrugsCovering: Novartis AG,F. Hoffmann-La Roche Ltd,Allergan Plc,Valeant Pharmaceuticals Intl Inc,Bayer AG

Ophthalmology Drugs Market Global Report 2018 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global ophthalmology drugs market.

Reasons to Purchase

Outperform competitors using accurate up to date demand-side dynamics information.

Identify growth segments for investment.

Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

Create regional and country strategies on the basis of local data and analysis.

Stay abreast of the latest customer and market research findings

Benchmark performance against key competitors.

Develop strategies based on likely future developments.

Utilize the relationships between key data sets for superior strategizing.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Gain a global perspective on the development of the market.

Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the ophthalmology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmology drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider Healthcare market, and compares it with other markets.

The market characteristics section of the report defines and explains the market.

The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down market into sub markets.

The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

The ophthalmology drugs market section of the report gives context. It compares the ophthalmology drugs market with other segments of the Healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

Scope

Markets Covered: Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmological Drugs

Companies Mentioned: Novartis AG,F. Hoffmann-La Roche Ltd,Allergan Plc,Valeant Pharmaceuticals Intl Inc,Bayer AG

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Ophthalmology Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Ophthalmology Drugs Market Characteristics
2. Ophthalmology Drugs Market Size And Growth
2.1. Historic Market Growth, Value ($ Billion) and Volume (Million Units)
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth, Value ($ Billion)
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market;
3. Ophthalmology Drugs Trends And Strategies;
4. Pestle Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental;
5. Ophthalmology Drugs Market Customer Information;
6. Ophthalmology Drugs Market Regional And Country Analysis
6.1. Global Ophthalmology Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
6.2. Global Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, By Region
6.3. Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Region
6.4. Global Ophthalmology Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
6.5. Global Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, By Country
6.6. Global Ophthalmology Drugs Market, Growth And Market Share Comparison, By Country
7. Ophthalmology Drugs Market Segmentation
7.1. Global Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
7.2. Global Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
8. Ophthalmology Drugs Market Segments
8.1.Antiglaucoma Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Antiglaucoma Drugs Market, 2017, By Segment, Value ($ Billion)
8.2.Dry Eye Medication
a) Market Characteristics
b) Market Trends & Strategies
c) Global Dry Eye Medication Market, 2017, By Segment, Value ($ Billion)
8.3.Other Ophthalmological Drugs
a) Market Characteristics
b) Market Trends & Strategies
c) Global Other Ophthalmological Drugs Market, 2017, By Segment, Value ($ Billion)
9. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors
9.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global
9.2. Per Capita Average Ophthalmology Drugs Expenditure, Global
10. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries
10.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country
10.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country
11. Ophthalmology Drugs Market Comparison With Industry Metrics
11.1. Global Number Of Pharmacists, 2017, By Country
11.2. Global Opthalmology Market Revenue Versus Number Of Pharmacists, 2017, By Country
11.3. Global Number Of Pharma Enterprises, 2017, By Country
11.4. Global Opthalmology Market Revenue Versus Number Of Pharma Enterprises, 2017, By Country
11.5. Global Average Spending On R&D/Product Development, 2017, By Country
11.6. Global Opthalmology Market Revenue Versus Average Spending On R&D/Product Development, 2017, By Country
11.7. Global Generic & Branded Sales Proportion By Country (Value), 2017, By Country
11.8. Global Opthalmology Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2017, By Country
11.9. Prevalent Cases Of Glaucoma, 2017, By Country
12. Asia-Pacific Ophthalmology Drugs Market
12.1.1. Asia-Pacific Ophthalmology Drugs Market Overview
12.1.2. Asia-Pacific Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.1.3. Asia-Pacific Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.1.4. Asia-Pacific Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
12.1.5. Asia-Pacific Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.2. Asia-Pacific Ophthalmology Drugs Market: Country Analysis
12.3. China Ophthalmology Drugs Market
12.3.1. China Ophthalmology Drugs Market Overview
12.3.2. China Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.3.3. China Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.3.4. China Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
12.3.5. China Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.4. India Ophthalmology Drugs Market
12.4.1. India Ophthalmology Drugs Market Overview
12.4.2. India Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.4.3. India Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.4.4. India Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
12.4.5. India Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.5. Japan Ophthalmology Drugs Market
12.5.1. Japan Ophthalmology Drugs Market Overview
12.5.2. Japan Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.5.3. Japan Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.5.4. Japan Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
12.5.5. Japan Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
12.6. Australia Ophthalmology Drugs Market
12.6.1. Australia Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
12.6.2. Australia Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
12.6.3. Australia Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
12.6.4. Australia Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13. Western Europe Ophthalmology Drugs Market
13.1.1. Western Europe Ophthalmology Drugs Market Overview
13.1.2. Western Europe Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.1.3. Western Europe Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.1.4. Western Europe Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
13.1.5. Western Europe Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.2. Western Europe Ophthalmology Drugs Market: Country Analysis
13.3. UK Ophthalmology Drugs Market
13.3.1. UK Ophthalmology Drugs Market Overview
13.3.2. UK Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.3.3. UK Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.3.4. UK Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
13.3.5. UK Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.4. Germany Ophthalmology Drugs Market
13.4.1. Germany Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.4.2. Germany Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.4.3. Germany Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
13.4.4. Germany Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.4.5. Germany Ophthalmology Drugs Market Comparison With Industry Metrics
13.5 France Ophthalmology Drugs Market
13.5.1 France Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.5.2 France Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.5.3. France Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
13.5.4. France Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.6. Italy Ophthalmology Drugs Market
13.6.1. Italy Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.6.2. Italy Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.6.3. Italy Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
13.6.4. Italy Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
13.7. Spain Ophthalmology Drugs Market
13.7.1. Spain Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
13.7.2. Spain Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
13.7.3. Spain Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
13.7.4. Spain Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14. Eastern Europe Ophthalmology Drugs Market
14.1.1. Eastern Europe Ophthalmology Drugs Market Overview
14.1.2. Eastern Europe Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.1.3. Eastern Europe Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
14.1.4. Eastern Europe Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
14.1.5. Eastern Europe Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
14.2. Eastern Europe Ophthalmology Drugs Market: Country Analysis
14.3. Russia Ophthalmology Drugs Market
14.3.1. Russia Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
14.3.2. Russia Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
14.3.3. Russia Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
14.3.4. Russia Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15. North America Ophthalmology Drugs Market
15.1.1. North America Ophthalmology Drugs Market Overview
15.1.2. North America Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.1.3. North America Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
15.1.4. North America Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
15.1.5. North America Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
15.2. North America Ophthalmology Drugs Market: Country Analysis
15.3. USA Ophthalmology Drugs Market
15.3.1. USA Ophthalmology Drugs Market Overview
15.3.2. USA Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
15.3.3. USA Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
15.3.4. USA Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
15.3.5. USA Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16. South America Ophthalmology Drugs Market
16.1.1. South America Ophthalmology Drugs Market Overview
16.1.2. South America Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.1.3. South America Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
16.1.4. South America Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
16.1.5. South America Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
16.2. South America Ophthalmology Drugs Market: Country Analysis
16.3. Brazil Ophthalmology Drugs Market
16.3.1. Brazil Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
16.3.2. Brazil Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
16.3.3. Brazil Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
16.3.4. Brazil Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
17. Middle East Ophthalmology Drugs Market
17.1.1. Middle East Ophthalmology Drugs Market Overview
17.1.2. Middle East Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
17.1.3. Middle East Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
17.1.4. Middle East Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
17.1.5. Middle East Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
18. Africa Ophthalmology Drugs Market
18.1.1. Africa Ophthalmology Drugs Market Overview
18.1.2. Africa Ophthalmology Drugs Historic Market, 2013 - 2017, Value ($ Billion) and Volume (Million Units)
18.1.3. Africa Ophthalmology Drugs Forecast Market, 2017 - 2021, Value ($ Billion)
18.1.4. Africa Ophthalmology Drugs Market, 2017, Segmentation By Type, Value ($ Billion)
Antiglaucoma Drugs
Dry Eye Medication
Other Ophthalmological Drugs
18.1.5. Africa Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, Segmentation By Type, Value ($ Billion)
19. Ophthalmology Drugs Market Competitive Landscape
19.1. Company Profiles
19.2. Novartis AG
19.2.1. Overview
19.2.2. Products And Services
19.2.3. Strategy
19.2.4. Financial Performance
19.3. F. Hoffmann-La Roche Ltd
19.3.1. Overview
19.3.2. Products And Services
19.3.3. Strategy
19.3.4. Financial Performance
19.4. Allergan Plc
19.4.1. Overview
19.4.2. Products And Services
19.4.3. Strategy
19.4.4. Financial Performance
19.5. Valeant Pharmaceuticals Intl Inc
19.5.1. Overview
19.5.2. Products And Services
19.5.3. Strategy
19.5.4. Financial Performance
19.6. Bayer AG
19.6.1. Overview
19.6.2. Products And Services
19.6.3. Strategy
19.6.4. Financial Performance
20. Key Mergers And Acquisitions In The Ophthalmology Drugs Market
21. Market Background: Ophthalmology Drugs Market
21.1.1. Ophthalmology Drugs Market Characteristics
21.1.2. Ophthalmology Drugs Market Historic Growth, Value ($ Billion)
21.1.2.1. Drivers Of The Market
21.1.2.2. Restraints Of The Market
21.1.3. Ophthalmology Drugs Market Forecast Growth, Value ($ Billion)
21.1.3.1. Drivers Of The Market
21.1.3.2. Restraints Of The Market
21.1.4. Ophthalmology Drugs Trends And Strategies
21.2. Ophthalmology Drugs Market Regional And Country Analysis
21.2.1. Global Ophthalmology Drugs Market, 2017, By Region, Value ($ Billion) and Volume (Million Units)
21.2.2. Global Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, By Region
21.2.3. Ophthalmology Drugs Market, 2017, By Country, Value ($ Billion) and Volume (Million Units)
21.2.4. Ophthalmology Drugs Market, 2013 - 2021, Historic And Forecast, By Country
21.2.5. Ophthalmology Drugs Market, Growth And Market Share Comparison, By Segment
21.2.6. Ophthalmology Drugs Market, Growth And Market Share Comparison, By Country And Segment
21.3. Global Ophthalmology Drugs Market Comparison With Macro Economic Factors
21.3.1. Ophthalmology Drugs Market Size, Percentage Of GDP, Global
21.3.2. Per Capita Average Ophthalmology Drugs Expenditure, Global
21.4. Ophthalmology Drugs Market Comparison With Macro Economic Factors Across Countries
21.4.1. Ophthalmology Drugs Market Size, Percentage Of GDP, By Country
21.4.2. Per Capita Average Ophthalmology Drugs Expenditure, By Country
21.5. Key Mergers And Acquisitions In The Ophthalmology Drugs Market
22. Appendix
22.1. NAICS Definitions Of Industry Covered In This Report
22.2. Abbreviations
22.3. Currencies
22.4. Research Inquiries
22.5. The Business Research Company
22.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report